• Nanoform successfully completes new share issue raising EUR 25 million to prepare for GMP manufacturing in the USA

  • Nanoform the stars that will shine the brightest with…

  • Global experts in nanotechnology and drug particle engineering

  • High-potent (30ng/m³)
    GMP capacity soon available
    as Nanoform triples capacity

Our latest videos


Improving the lives of patients globally by overcoming drug development and delivery challenges through our game changing technologies.
Enhanced by the most talented minds in physics, AI, biology and engineering, our nanoparticle engineering, formulation and GMP manufacturing services can drive forward your market success and unlock the power of ‘’small’’.

About Nanoform


Our work enables our partners to overcome drug development challenges to rapidly progress novel drugs to market. We are driven by a passion for innovation, and constantly work to find ground-breaking solutions that enhance drug effectiveness and targeting.

Expert services

Our nanoforming services provide solutions to complex formulation challenges by increasing drug solubility and bioavailability. The advanced production of nanoparticles provides pharmacokinetic improvements, commercial opportunities and novel avenues for drug delivery.

GMP Manufacturing


Our experienced team are able to manufacture API nanoparticles created by our award-winning CESS® small-molecule nanoparticle engineering technology to GMP standards. Our GMP facility is currently able to handle OEB4 (1ug/m3) compounds.

Working together for enhanced drug development

Our nanoforming technologies and services span the full range of drug development from small-molecule nanoparticles to large-molecule biologics. We support all phases of drug development, accelerating your time to clinic for GMP manufacture while also increasing possibilities and probabilities of success in taking your product to market.

Nanoform’s platform is exciting for its broad applicability to drug development across all therapeutic areas

Gary Buell
ex-Director, Search & Evaluation, Merck Serono